Invention Grant
- Patent Title: Use of cyclolignans and new cyclolignans
- Patent Title (中): 使用环烷基和新的环烷基
-
Application No.: US11346294Application Date: 2006-02-03
-
Publication No.: US07709526B2Publication Date: 2010-05-04
- Inventor: Olle Larsson , Magnus Axelson
- Applicant: Olle Larsson , Magnus Axelson
- Applicant Address: SE Stockholm
- Assignee: Biovitrum AB
- Current Assignee: Biovitrum AB
- Current Assignee Address: SE Stockholm
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, P.C.
- Priority: SE0102168 20010619
- Main IPC: A61K31/335
- IPC: A61K31/335 ; C07D317/70
Abstract:
Compounds which inhibit the insulin-like growth factor-1 receptor (IGF-1 R) and methods for using them for treating IGF-1 R dependent diseases, such as cancer.
Public/Granted literature
- US20060154982A1 Use of cyklolignans and new cyklolignans Public/Granted day:2006-07-13
Information query
